Stress kinases in the modulation of metabolism and energy balance
- PMID: 26363062
- PMCID: PMC5176079
- DOI: 10.1530/JME-15-0146
Stress kinases in the modulation of metabolism and energy balance
Abstract
Obesity is a new global pandemic, with growing incidence and prevalence. This disease is associated with increased risk of several pathologies, including diabetes, cardiovascular diseases, and cancer. The mechanisms underlying obesity-associated metabolic changes are the focus of efforts to identify new therapies. Stress-activated protein kinases (SAPK), including cJun N-terminal kinases (JNKs) and p38, are required for cellular responses to metabolic stress and therefore might contribute to the pathogenesis of obesity. Tissue-specific knockout models support a cell-type-specific role for JNK isoforms, in particular JNK1, highlighting its importance in cell homeostasis and organ crosstalk. However, more efforts are needed to elucidate the specific roles of other JNK isoforms and p38 family members in metabolism and obesity. This review provides an overview of the role of SAPKs in the regulation of metabolism.
Keywords: JNK; SAPK; adipose tissue; brain and signal transduction; metabolism; obesity; p38; stress.
© 2015 Society for Endocrinology.
Figures
Similar articles
-
Brain JNK and metabolic disease.Diabetologia. 2021 Feb;64(2):265-274. doi: 10.1007/s00125-020-05327-w. Epub 2020 Nov 16. Diabetologia. 2021. PMID: 33200240 Review.
-
Stress-activated kinase pathway alteration is a frequent event in bladder cancer.Urol Oncol. 2012 Jul-Aug;30(4):415-20. doi: 10.1016/j.urolonc.2010.03.002. Epub 2011 Dec 11. Urol Oncol. 2012. PMID: 22154358
-
JNK and p38 mitogen-activated protein kinase pathways contribute to porcine epidemic diarrhea virus infection.Virus Res. 2016 Aug 15;222:1-12. doi: 10.1016/j.virusres.2016.05.018. Epub 2016 May 20. Virus Res. 2016. PMID: 27215486 Free PMC article.
-
Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.Cancer Res. 2000 Sep 15;60(18):5067-73. Cancer Res. 2000. PMID: 11016630
-
Current advances on different kinases involved in tau phosphorylation, and implications in Alzheimer's disease and tauopathies.Curr Alzheimer Res. 2005 Jan;2(1):3-18. doi: 10.2174/1567205052772713. Curr Alzheimer Res. 2005. PMID: 15977985 Review.
Cited by
-
Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.Int J Mol Sci. 2023 Sep 16;24(18):14177. doi: 10.3390/ijms241814177. Int J Mol Sci. 2023. PMID: 37762479 Free PMC article. Review.
-
Experimental and Computational Investigation of the Oxime Bond Stereochemistry in c-Jun N-terminal Kinase 3 Inhibitors 11H-Indeno[1,2-b]quinoxalin-11-one Oxime and Tryptanthrin-6-oxime.Pharmaceutics. 2023 Jun 23;15(7):1802. doi: 10.3390/pharmaceutics15071802. Pharmaceutics. 2023. PMID: 37513989 Free PMC article.
-
Melanocortin 1 receptor regulates cholesterol and bile acid metabolism in the liver.Elife. 2023 Jul 25;12:e84782. doi: 10.7554/eLife.84782. Elife. 2023. PMID: 37490042 Free PMC article.
-
Identification of key genes and pathways revealing the central regulatory mechanism of brain-derived glucagon-like peptide-1 on obesity using bioinformatics analysis.Front Neurosci. 2022 Aug 5;16:931161. doi: 10.3389/fnins.2022.931161. eCollection 2022. Front Neurosci. 2022. PMID: 35992905 Free PMC article.
-
Reducing White Adipose Tissue Browning Using p38α MAPK Inhibitors Ameliorates Cancer-Associated Cachexia as Assessed by Magnetic Resonance Imaging.Nutrients. 2022 Jul 22;14(15):3013. doi: 10.3390/nu14153013. Nutrients. 2022. PMID: 35893867 Free PMC article.
References
-
- Aguirre V, Uchida T, Yenush L, Davis R, White MF. The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307) J Biol Chem. 2000;275:9047–9054. - PubMed
-
- Belgardt BF, Bruning JC. CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci. 2010;1212:97–113. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
